Guardant Health Inc. Logo

Guardant Health Inc. (5GH)

FSX

Currency in EUR
149.28
-2.74 (-1.80%)

Closed

Oct 8, 2026

Day's Range

149.28
149.28

52 wk Range

52.94
166.44

Overview - 5GH - Guardant Health Inc.

Key Statistics

Valuation

Enterprise Value

18.99B

P/E (Trailing)

‪-47.14‬

P/E (Forward)

‪-46.44‬

PEG Ratio

‪-3.77‬

Price / Sales (TTM)

‪17.75‬

Price / Book

‪-93.31‬

EV / EBITDA

‪-50.27‬

Profitability

Gross Margin

‪65.38%‬

Profit Margin

‪-38.32%‬

Operating Margin

‪-38.24%‬

Return on Assets

‪-18.07%‬

Return on Equity

‪419.18%‬

Ownership

Shares Outstanding

133.61M

Float

129.47M

Held by Insiders

‪3.96%‬

Held by Institutions

‪100.90%‬

Price stats

Beta

‪1.57‬

50-Day Avg

‪140.72‬

200-Day Avg

‪105.29‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 5GH - Guardant Health Inc.

News & Analysis

View all news

Market Cap - 5GH - Guardant Health Inc.

Peers - 5GH - Guardant Health Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on FSX.

Profile Summary - 5GH - Guardant Health Inc.

About

Guardant Health Inc. is a precision oncology company that develops blood- and tissue-based tests, data sets, and analytics to support cancer detection and treatment decisions. Its product portfolio includes liquid biopsy tests for tumor mutation profiling, molecular residual disease monitoring, tissue-based genomic…

SectorHealthcare
IndustryDiagnostics & Research
Employees2.49K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.